Adherence of subjects with cystic fibrosis to their home program: A systematic review

Respiratory Care

Volumn 59, Issue 11, 2014, Pages 1731-1746

  O’Donohoe, Ruairi ^a   Fullen, Brona M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Adherence; Cystic fibrosis; Home treatment program; Systematic review

Indexed keywords

ANTIBIOTIC AGENT; BRONCHODILATING AGENT; DEOXYRIBONUCLEASE;

CYSTIC FIBROSIS; ENZYME REPLACEMENT; EXERCISE; HUMAN; LUNG CLEARANCE; MEDICAL NEBULIZER; NUTRITION; PATIENT COMPLIANCE; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; HOME CARE; ORGANIZATION AND MANAGEMENT;

CYSTIC FIBROSIS; HOME CARE SERVICES; HUMANS; PATIENT COMPLIANCE;

EID: 84926198675     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02990     Document Type: Review

References (63)

1. Baum A, Newman S, Weinman J, West R, McManus C. The Cambridge handbook of psychology, health and medicine. Cambridge: Cambridge University Press; 1997.
2. Cystic Fibrosis Foundation Patient Registry 2011 Annual Data Report. Cystic Fibrosis Foundation; 2012. http://www.cff.org/uploaded files/research/clinicalresearch/2011-patient-registry.pdf. Accessed October 30, 2011.
3. Modi AC, Lim CS, Yu N, Geller D, Wagner MH, Quittner AL. A multi-method assessment of treatment adherence for children with cystic fibrosis. J Cyst Fibros 2006;5(3):177-185.
4. Marciel KK, Saiman L, Quittell LM, Dawkins K, Quittner AL. Cell phone intervention to improve adherence: cystic fibrosis care team, patient, and parent perspectives. Pediatr Pulmonol 2010;45(2):157-164.
5. Sawicki GS, Sellers DE, Robinson WM. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros 2009;8(2):91-96.
6. Geller DE, Madge S. Technological and behavioral strategies to reduce treatment burden and improve adherence to inhaled antibiotics in cystic fibrosis. Respir Med 2011;105(Suppl 2):S24-S31.
7. Cockburn J, Gibberd RW, Reid AL, Sanson-Fisher R. Determinants of noncompliance with short-term antibiotic regimens. BMJ 1987; 295(6602):814-818.
8. Elkins MR, Robinson M, Rose BR, Harbour C, Moriarty CP, Marks GB, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006;354(3):229-240.
9. Quinn J, Latchford G, Duff A, Conner M, Pollard K, Morrison L, et al. Measuring, predicting and improving adherence to inhalation in patients with CF: a randomised controlled study of motivational interviewing. Pediatr Pulmonol 2004;38(S27):360.
10. DeLambo KE, Ievers-Landis CE, Drotar D, Quittner AL. Association of observed family relationship quality and problem-solving skills with treatment adherence in older children and adolescents with cystic fibrosis. J Pediatr Psychol 2004 29(5):343-353.
11. Zindani GN, Streetman DD, Streetman DS, Nasr SZ. Adherence to treatment in children and adolescent patients with cystic fibrosis. J Adolesc Health 2006;38(1):13-17.
12. Passero MA, Remor B, Salomon J. Patient-reported compliance with cystic fibrosis therapy. Clin Pediatr 1981;20(4):264-268.
13. Weiner JR, Toy EL, Sacco P, Duh MS. Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature. Expert Opin Pharmacother 2008;9(5):751-766.
14. Main E, Prasad A, van der Schans CP. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. Cochrane Database Syst Rev 2005:(1):CD002011.
15. Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shevlin N. Medication compliance: a healthcare problem. Ann Pharmacother 1993; 27(9 Suppl):S1-S24.
16. Bauman LJ, Wright E, Leickly FE, Crain E, Kruszon-Moran D, Wade SL, Visness CM. Relationship of adherence to pediatric asthma morbidity among inner-city children. Pediatrics 2002;110(1 Pt 1):e6.
17. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992;326(13):862-866.
18. Briesacher BA, Quittner AL, Saiman L, Sacco P, Fouayzi H, Quittell LM. Adherence with tobramycin inhaled solution and health care utilization. BMC Pulm Med 2011;11:5.
19. de Abreu Silva FA, Dodge JA. Guidelines for the diagnosis and management of cystic fibrosis. World Health Organization, 1996. http://www.cfww.org/who/article/198/guidelines_for_the_diagnosis_ and_management_of%20cystic_fibrosis. Accessed June 6, 2014.
20. Thomas BH, Ciliska D, Dobbins M, Micucci S. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid Based Nurs 2004;1(3):176-184.
21. Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating non-randomised intervention studies. Health Technol Assess 2003;7(27)::iii-x,1-173.
22. Eddy ME, Carter BD, Kronenberger WG, Conradsen S, Eid NS, Bourland SL, Adams G. Parent relationships and compliance in cystic fibrosis. J Pediatr Health Care 1998;12(4):196-202.
23. Myers LB, Myers F. The relationship between control beliefs and self-reported adherence in adults with cystic fibrosis. Psychol Health Med 1999;4(4):387-391.
24. Ward C, Massie J, Glazner J, Sheehan J, Canterford L, Armstrong D, et al. Problem behaviours and parenting in preschool children with cystic fibrosis. Arch Dis Child 2009;94(5):341-347.
25. Dalcin Pde T, Rampon G, Pasin LR, Ramon GM, Abrahaõ CL, Oliveira VZ. [Adherence to treatment in patients with cystic fibrosis]. J Bras Pneumol 2007;33(6):663-670. Article in Portuguese.
26. Myers LB, Horn SA. Adherence to chest physiotherapy in adults with cystic fibrosis. J Health Psychol 2006;11(6):915-926.
27. Arias Llorente RP, Bousonõ García C, Díaz Martín JJ. Treatment compliance in children and adults with cystic fibrosis. J Cyst Fibros 2008;7(5):359-367.
28. Hobbs SA, Schweitzer JB, Cohen LL, Hayes AL, Schoell C, Crain BK. Maternal attributions related to compliance with cystic fibrosis treatment. J Clin Psychol Med Settings 2003;10(4):273-277.
29. Abbott J, Dodd M, Bilton D, Webb AK. Treatment compliance in adults with cystic fibrosis. Thorax 1994;49:(2):115-120.
30. White D, Stiller K, Haensel N. Adherence of adult cystic fibrosis patients with airway clearance and exercise. J Cyst Fibros 2007;6(3): 163-170.
31. White T, Miller J, Smith GL, McMahon WM. Adherence and psychopathology in children and adolescents with cystic fibrosis. Eur Child Adolesc Psychol 2009;18(2):96-104.
32. Daniels T, Goodacre L, Sutton C, Pollard K, Conway S, Peckham D. Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers. Chest 2011;140(2):425-432.
33. Latchford G, Duff A, Quinn J, Conway S, Conner M. Adherence to nebulised antibiotics in cystic fibrosis. Patient Educ Counsel 2009; 75(1):141-144.
34. McNamara PS, McCormack P, McDonald AJ, Heaf L, Southern KW. Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis. J Cyst Fibros 2009;8(4):258-263.
35. Eakin MN, Bilderback A, Boyle MP, Mogayzel PJ, Riekert KA. Longitudinal association between medication adherence and lung health in people with cystic fibrosis. J Cyst Fibros 2011;10(4):258-264.
36. Burrows JA, Bunting JP, Masel PJ, Bell SC. Nebulised dornase alpha: adherence in adults with cystic fibrosis. J Cyst Fibros 2002; 1(4):255-259.
37. Adde FV, Rodrigues JC, Cardoso AL. Nutritional follow-up of cystic fibrosis patients: the role of nutrition education. J Pediatr 2004;80(6): 475-482.
38. Simon SL, Duncan CL, Horky SC, Nick TG, Castro MM, Riekert KA. Body satisfaction, nutritional adherence, and quality of life in youth with cystic fibrosis. Pediatr Pulmonol 2011;46(11):1085-1092.
39. Schall JI, Bentley T, Stallings VA. Meal patterns, dietary fat intake and pancreatic enzyme use in preadolescent children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2006;43(5):651-659.
40. Gayer D, Ganong L. Family structure and mothers’ caregiving of children with cystic fibrosis. J Fam Nurs 2006;12(4):390-412.
41. Borowitz D, Wegman T, Harris M. Preventive care for patients with chronic illness. Multivitamin use in patients with cystic fibrosis. Clin Pediatr 1994;33(12):720-725.
42. Hollander FM, de Roos NM, Dopheide J, Hoekstra T, van Berkhout FT. Self-reported use of vitamins and other nutritional supplements in adult patients with cystic fibrosis. Is daily practice in concordance with recommendations? Int J Vitam Nutr Res 2010; 80(6):408-415.
43. Anthony H, Paxton S, Bines J, Phelan P. Psychosocial predictors of adherence to nutritional recommendations and growth outcomes in children with cystic fibrosis. J Psychosom Res 1999; 47(6):623-634.
44. Lu M, Safren SA, Skolnik PR, Rogers WH, Coady W, Hardy H, Wilson IB. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav 2008;12(1):86-94.
45. Walsh JC, Horne R, Dalton M, Burgess AP, Gazzard BG. Reasons for non-adherence to antiretroviral therapy: patients’ perspectives provide evidence of multiple causes. AIDS Care 2001;13(6):709-720.
46. Woloshin S, Schwartz LM, Welch HG. Patients and medical statistics. Interest, confidence and ability. J Gen Intern Med 20(11):996-1000, 2005.
47. Quittner AL, Drotar D, Ievers-Landis CE, Seidner D, Slocum N, Jacobsen J. Adherence to medical treatments in adolescents with cystic fibrosis: the development and evaluation of family-based interventions. In: Drotar D, editor. Promoting adherence to medical treatment in childhood chronic illness: interventions and methods. Hillsdale, New Jersey: Lawrence Erlbaum Associates; 2000:383-407.
48. Quittner AL, Espelage DL, Ievers-Landis CE, Drotar D. Measuring adherence to medical treatments in childhood chronic illness: considering multiple methods and sources of information. J Clin Psychol Med Settings 2000;7(1):41-54.
49. Davies JC, Wainwright CE, Canny GJ, Chilvers MA, Howenstine MS, Munck A, et al. Efficacy and safety of ivacaftor in patients aged 6 to 11 y with cystic fibrosis with a G551D mutation. Am J Respir Crit Care Med 2013;187(11):1219-1225.
50. Simmonds MJ, Olson SL, Jones S, Hussein T, Lee CE, Novy D, Radwan H. Psychometric characteristics and clinical usefulness of physical performance tests in patients with low back pain. Spine 1998;23(22):2412-2421.
51. Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, Chang CJ. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis 2001;33(8):1417-1423.
52. Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001;134(10):968-977.
53. Wagner GJ, Kanouse DE, Koegel P, and Sullivan G. Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care 2004;16(4):501-506.
54. Rothert ML. Physicians’ and patients’ judgments of compliance with a hypertensive regimen. Med Decis Making 1982;2(2):179-195.
55. Bogart LM, Catz SL, Kelly JA, Benotsch EG. Factors influencing physicians’ judgments of adherence and treatment decisions for patients with HIV disease. Med Decis Making 2001;21(1):28-36.
56. Fullen BM, Doody C, Baxter GD, Daly LE, Hurley DA. Chronic low back pain: non-clinical factors impacting on management by Irish doctors. Ir J Med Sci. 2008;177(3):257-263.
57. Wagner GJ, Rabkin JG. Measuring medication adherence: are missed doses reported more accurately then perfect adherence? AIDS Care 2000;12(4):405-408.
58. Barfod TS, Sørensen HT, Nielsen H, Rodkjaer L, Obel N. ‘Simply forgot’ is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence. HIV Med 2006;7(5): 285-290.
59. Sabaté E. Defining adherence. Adherence to long-term therapies: evidence for action. World Health Organization, 2003. http://www.who.int/chp/knowledge/publications/adherence:report/en. Accessed June 6, 2014.
60. Conway SP, Pond MN, Hamnett T, Watson A. Compliance with treatment in adult patients with cystic fibrosis. Thorax 1996;51(1): 29-33.
61. Logan AG. Transforming hypertension management using mobile health technology for telemonitoring and self-care support. Can J Cardiol 2013;29(5):579-585.
62. Ma J, Xiao L, Blonstein AC. Measurement of self-monitoring web technology acceptance and use in an e-health weight-loss trial. Telemed J E Health 2013;19(10):739-745.
63. El-Gayar O, Timsina P, Nawar N, Eid W. A systematic review of IT for diabetes self-management: are we there yet? Int J Med Inform 2013;82(8):637-652.